Provided by Chambers
Hogan Lovells defended Novartis and its generic division Sandoz in a qui tam action alleging pricing violations and overcharging federal health programs. The firm successfully dismissed the action and continued to defend the dismissal before the Ninth Circuit.
Provided by Chambers
It is always easy to get a hold of the individuals and they have done very well in outlining and keeping to aggressive timelines related to the review of volumes of documents and the drafting of communications.
The attorneys are very sharp and practical.
The attorneys are always there for us.
It is a great FCA team with long-running relationships and aggressive advocacy against overreach.
The attorneys are reactive, proactive and anticipate trends.
It is always easy to get a hold of the individuals and they have done very well in outlining and keeping to aggressive timelines related to the review of volumes of documents and the drafting of communications.
The attorneys are very sharp and practical.
The attorneys are always there for us.
It is a great FCA team with long-running relationships and aggressive advocacy against overreach.
The attorneys are reactive, proactive and anticipate trends.
Provided by Chambers
Jonathan is a fantastic FCA litigator. His expertise around the law, understanding of DOJ thinking, and creative arguments are a perfect fit for responding to government investigations that touch-sensitive business decisions.
The combination of his prior government experience, general knowledge of the False Claims Act, sophistication in particular in the health care arena, and ability to find creative solutions, makes him one of the top False Claims Act practitioners in my experience.
He is practical and responsive to our specific needs.
Mitchell is likeable and authoritative, but not overpowering.
Mitchell really leads on our challenging issues; his experience is unrivalled.